Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose topiramate in migraine prophylaxis
IRCT20250508065645N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of topiramate in migraine, sponsored by Tehran University of Medical Sciences. Started Jun 2025; status: completed.
02
Drugs
topiramate
03
Conditions
migraine
Beyond the preview
Go deeper on IRCT20250508065645N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250508065645N1.